This inventor holds 2 USPTO granted patents and 3 published patent applications, plus 2 CIPO patents and 3 EPO patents. Top assignee: Centre National De La Recherche Scientifique. Active years: 2013-2016.
Company Filing History:
Years Active: 2013-2016
Title: Yamina Hamma: Innovator in Cancer Treatment
Introduction
Yamina Hamma is a prominent inventor based in Le Kremlin Bicetre, France. She has made significant contributions to the field of cancer treatment through her innovative research and development of synthetic ligands.
Latest Patents
Yamina Hamma holds 2 patents related to the use of multivalent synthetic ligands of surface nucleolin for treating cancer or inflammation. Her latest patents describe a method for treating disorders involving deregulation of cell proliferation and/or angiogenesis. This method comprises the administration of an effective amount of a multivalent synthetic compound that includes a support on which at least three pseudopeptide units are grafted.
Career Highlights
Throughout her career, Yamina has worked with esteemed organizations such as the Centre National de la Recherche Scientifique and Université Paris Est Créteil Val de Marne. Her work has focused on advancing therapeutic methods that target critical pathways in cancer and inflammation.
Collaborations
Yamina has collaborated with notable professionals in her field, including Ara G. Hovanessian and Jean Paul Briand. These collaborations have further enriched her research and contributed to her innovative approaches in cancer treatment.
Conclusion
Yamina Hamma's work exemplifies the intersection of innovation and healthcare, particularly in the fight against cancer. Her patents and collaborations highlight her commitment to advancing medical science and improving patient outcomes.